Latest Perelman School of Medicine at the University of Pennsylvania Stories
-- CHOP and Penn Medicine Experts Define Riskier Mutations in Neuroblastoma, Setting Stage for Clinical Trial-- PHILADELPHIA, Nov.
334,000 Square Foot Life Science Facility is Home to Penn Medicine University City, Good Shepherd Penn Partners, Spark Therapeutics and Corner Bakery PHILADELPHIA, Sept.
New Facility Expands Penn Medicine's Footprint in University City, Paves Way for Year of Milestone Expansions for Penn Presbyterian Medical Center PHILADELPHIA, Sept.
New Facility Poised to Accelerate the Research and Development of Personalized Cellular Cancer Therapies PHILADELPHIA, Sept.
Appointment is effective October 1, 2014 Philadelphia, PA (PRWEB) July 25, 2014
Engineered Cells Known As CTL019 Are the First Therapy of Their Kind to Obtain Designation PHILADELPHIA, July 7, 2014 /PRNewswire/ -- A University of Pennsylvania-developed personalized
Extended, year-long series ‘Medical Breakthroughs from Penn Medicine’ presents expert interviews highlighting the newest medical advancements in oncology, cardiology, neurology, orthopedics,
ANN ARBOR, Mich., June 4, 2014 /PRNewswire-USNewswire/ -- A physician-scientist who developed a personalized immunotherapy for leukemia using patients' own T cells is the recipient of the 2014
- A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.